105 related articles for article (PubMed ID: 21427594)
1. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging.
Motosugi U; Ichikawa T; Onohara K; Sou H; Sano K; Muhi A; Araki T
Invest Radiol; 2011 Jun; 46(6):359-65. PubMed ID: 21427594
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
Chou CT; Chen YL; Su WW; Wu HK; Chen RC
J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
[TBL] [Abstract][Full Text] [Related]
3. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.
Doo KW; Lee CH; Choi JW; Lee J; Kim KA; Park CM
AJR Am J Roentgenol; 2009 Dec; 193(6):W490-6. PubMed ID: 19933623
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
5. Focal eosinophilic infiltration of the liver: gadoxetic acid-enhanced magnetic resonance imaging and diffusion-weighted imaging.
Ahn SJ; Choi JY; Kim KA; Kim MJ; Baek SE; Kim JH; Song HT
J Comput Assist Tomogr; 2011; 35(1):81-5. PubMed ID: 21160434
[TBL] [Abstract][Full Text] [Related]
6. Hepatic haemangioma: dynamic MRI using gadolinium-DTPA.
Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M
Eur J Radiol; 1987 Nov; 7(4):257-9. PubMed ID: 3691543
[TBL] [Abstract][Full Text] [Related]
7. [Magnetic resonance tomography of focal hepatic lesions using the para-magnetic contrast medium, gadolinium DTPA. First clinical results].
Hamm B; Römer T; Felix R; Wolf KJ
Rofo; 1986 Dec; 145(6):684-91. PubMed ID: 3025957
[TBL] [Abstract][Full Text] [Related]
8. Characterization of hyperintense nodules on precontrast T1-weighted MRI: utility of gadoxetic acid-enhanced hepatocyte-phase imaging.
Chou CT; Chen YL; Wu HK; Chen RC
J Magn Reson Imaging; 2011 Mar; 33(3):625-32. PubMed ID: 21563246
[TBL] [Abstract][Full Text] [Related]
9. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
10. Conspicuity of liver hemangiomas: short tau inversion recovery, T1, and T2 imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid.
Brody JM; Schafer L; Tung GA; Breuer J; Shamsi K
J Magn Reson Imaging; 2005 Apr; 21(4):391-7. PubMed ID: 15778951
[TBL] [Abstract][Full Text] [Related]
11. Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver disease.
Motosugi U; Ichikawa T; Sano K; Sou H; Onohara K; Muhi A; Kitamura T; Amemiya F; Enomoto N; Matsuda M; Asakawa M; Fujii H; Araki T
Invest Radiol; 2011 Feb; 46(2):141-5. PubMed ID: 21139506
[TBL] [Abstract][Full Text] [Related]
12. [MRI in the differential diagnosis of liver focal lesions].
Negru D; Fotea V; Grigoraş M; Moisii L; Daniil C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):548-54. PubMed ID: 17571543
[TBL] [Abstract][Full Text] [Related]
13. Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings.
Huppertz A; Balzer T; Blakeborough A; Breuer J; Giovagnoni A; Heinz-Peer G; Laniado M; Manfredi RM; Mathieu DG; Mueller D; Reimer P; Robinson PJ; Strotzer M; Taupitz M; Vogl TJ;
Radiology; 2004 Jan; 230(1):266-75. PubMed ID: 14695400
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver.
Chung SH; Kim MJ; Choi JY; Hong HS
J Magn Reson Imaging; 2010 Feb; 31(2):365-72. PubMed ID: 20099350
[TBL] [Abstract][Full Text] [Related]
15. [Differentiation of focal liver lesions using contrast-enhanced MRT].
Heintz P; Ehrenheim C
Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of liver parenchyma after injection of hepatocyte-specific MRI contrast media: a comparison of gadoxetic acid and gadobenate dimeglumine.
Filippone A; Blakeborough A; Breuer J; Grazioli L; Gschwend S; Hammerstingl R; Heinz-Peer G; Kittner T; Laghi A; Leen E; Lencioni R; Lucidarme O; Remplik P; Robinson PJ; Ruehm SG; Schaefer F; Stoupis C; Tombach B; Valette PJ; Zech CJ; Huppertz A
J Magn Reson Imaging; 2010 Feb; 31(2):356-64. PubMed ID: 20099349
[TBL] [Abstract][Full Text] [Related]
17. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
Tamada T; Ito K; Yoshida K; Sone T; Murakami K; Kanki A; Watanabe S; Higashi H; Yamashita T
J Comput Assist Tomogr; 2010; 34(2):182-6. PubMed ID: 20351500
[TBL] [Abstract][Full Text] [Related]
18. MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients.
Giovanoli O; Heim M; Terracciano L; Bongartz G; Ledermann HP
AJR Am J Roentgenol; 2008 May; 190(5):W290-3. PubMed ID: 18430814
[TBL] [Abstract][Full Text] [Related]
19. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
20. [Dynamic MRI of liver tumors--evaluation by inversion recovery snap shot FLASH MR imaging].
Murakami T; Mitani T; Nishikawa M; Nakanishi K; Marukawa T; Harada K; Tokunaga K; Kuroda C; Kozuka T
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Nov; 50(11):1451-3. PubMed ID: 1965025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
